Streetbeat News

Stock Prices

IDYA

IDEAYA Biosciences presented Phase 1 expansion data for IDE397 in patients with specific genetic deletions in urothelial and non-small cell lung cancers. The data was shared as a late breaker abstract oral presentation.

Portfolio Pulse from Nabaparna Bhattacharya

October 25, 2024 | 10:04 am

AON

Aon reported Q3 2024 earnings of $2.72 per share, surpassing the $2.48 estimate, and sales of $3.72 billion, exceeding the $3.69 billion estimate. This marks a significant year-over-year growth in both earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 10:02 am

TSLA

Tesla's stock experienced a 2% decline in pre-market trading following a massive 22% rally, as investors locked in profits. The rally was driven by increased options activity and Tesla's announcement of its highest quarterly profit since mid-2023.

Portfolio Pulse from Pooja Rajkumari

October 25, 2024 | 9:42 am

POR

Portland General Electric has updated its 2024 adjusted EPS outlook to a range of $3.08 to $3.18, narrowing from the previous range of $2.98 to $3.18. This aligns with the consensus estimate of $3.08.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 9:06 am

AAPL

AMZN

BELT

FBGRX

META

MSFT

NVDA

TSLA

Major U.S. investment funds are selling shares to comply with IRS tax regulations due to a tech-driven stock market surge. This affects funds like Fidelity and T Rowe Price, as tech giants like Nvidia, Apple, Meta, Microsoft, and Amazon account for a significant portion of market gains.

Portfolio Pulse from Benzinga Neuro

October 25, 2024 | 8:33 am

AN

CL

HCA

IBM

TSLA

The S&P 500 ended its 3-day losing streak, driven by a 22% surge in Tesla shares following strong Q3 earnings. IBM shares fell 6.2% due to a revenue miss. The Fear & Greed Index remains in the 'Greed' zone, indicating positive market sentiment. Investors await earnings from AutoNation, Colgate-Palmolive, and HCA Healthcare.

Portfolio Pulse from Avi Kapoor

October 25, 2024 | 8:24 am

RVMD

Revolution Medicines' RMC-9805 shows a 30% response rate in early trials for pancreatic cancer, indicating potential as a treatment for RAS-addicted cancers. The drug demonstrated a favorable safety profile and significant antitumor activity, with a disease control rate of 80%.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 8:22 am

EWG

Germany's business expectations for October have improved to 87.3, surpassing the estimated 86.8 and the revised prior figure of 86.4. This positive change may influence ETFs like EWG, which track German economic performance.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 8:06 am

AN

CL

COF

EW

HCA

AutoNation, Capital One Financial, Colgate-Palmolive, Edwards Lifesciences, and HCA Healthcare are stocks to watch as they report earnings. Capital One exceeded expectations, while Edwards Lifesciences missed sales estimates.

Portfolio Pulse from Avi Kapoor

October 25, 2024 | 7:53 am

TSLA

Elon Musk's wealth surged by $33.5 billion as Tesla's stock rose 22%, marking its best performance in over a decade. This was driven by Tesla's highest quarterly profit since mid-2023 and a positive vehicle sales outlook. The company's market value increased by nearly $150 billion.

Portfolio Pulse from Pooja Rajkumari

October 25, 2024 | 7:38 am